For laboratory research use only. Not for human consumption. Not for medical, diagnostic, or therapeutic use.
← Back to Products

RESEARCH PRODUCT PROFILE

Sold out

Retatrutide 40mg Pen

Retatrutide 40mg supplied in a pre-filled research device for controlled laboratory use. This 40mg format is designed for teams running protocol work, concentration-dependent comparison studies, and extended non-clinical laboratory evaluation programs.

£149.99

UK domestic shipping included when available. Estimated delivery 1–3 business days after payment confirmation.

Product Instructions Request COA
Retatrutide 40mg Peptiv8 research pen packaging

Format: Pre-filled research pen

Amount: 40mg Retatrutide per device

Purity: >99% (batch-specific COA)

Intended use: Laboratory and in-vitro research only

Product overview

The 40mg format is selected where research frameworks require higher-concentration inventory control, broader assay range planning, and consistent batch handling across repeat analytical cycles.

Quality and documentation

  • Every batch is supplied with a Certificate of Analysis (COA).
  • COA documentation verifies batch identity and purity metrics against release criteria.
  • Purity specification for supply is greater than 99%.

Handling and storage

  • Store refrigerated at 2–8°C.
  • Do not freeze.
  • Maintain sealed format until laboratory use.
  • Follow internal SOPs for controlled handling and documentation retention.

Compliance notice

This product is supplied strictly for laboratory research and analytical use by qualified purchasers. It is not for human consumption, not for therapeutic use, and not for diagnostic or medical application.